Cargando…
Economic Burden of Epidermolysis Bullosa Disease in Iran
Background: Epidermolysis bullosa (EB) is prevalent in Iran and incurs direct and indirect costs on the health care system and the patient. Therefore, this study was conducted to estimate the economic burden of this disease in Iran. Methods: This study includes all patients with EB disease who had b...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840875/ https://www.ncbi.nlm.nih.gov/pubmed/35321378 http://dx.doi.org/10.47176/mjiri.35.146 |
_version_ | 1784650722634104832 |
---|---|
author | Forghani, Siamak Farokh Jahangiri, Reza Ghasemi, Farzaneh Shirani, Reza Bagheri, Hosein Mahmoodi, Razieh Bagheri Faradonbeh, Saeed |
author_facet | Forghani, Siamak Farokh Jahangiri, Reza Ghasemi, Farzaneh Shirani, Reza Bagheri, Hosein Mahmoodi, Razieh Bagheri Faradonbeh, Saeed |
author_sort | Forghani, Siamak Farokh |
collection | PubMed |
description | Background: Epidermolysis bullosa (EB) is prevalent in Iran and incurs direct and indirect costs on the health care system and the patient. Therefore, this study was conducted to estimate the economic burden of this disease in Iran. Methods: This study includes all patients with EB disease who had been referred to the medical centers of Iran in 2019-2020 for treatment of their disease, especially Hazrat Fatimah Hospital and their medical records are available in Iran EB Patients Association (IEBPA). In estimating the economic burden of diseases and costing studies, we calculated the average direct and indirect costs for a patient and used it to estimate the costs of the patient population. In this study, a prevalence approach was used to calculate the economic burden of this disease. For this purpose, the existing cases of the disease in 2019-2020 were calculated. The data collected from the questionnaires that were completed through interviews with patients as well as the data extracted from the review of their files were entered into Excel software and analyzed. Results: The total direct medical costs of direct non-medical and indirect are equal to 7.319.428.315 & 5.390.440.775 and 45.875.654.514 Rials respectively, and the total economic burden of the disease and the average of each patient is 58.585.514.604 and 155.890.789 respectively. Conclusion: High indirect costs, especially informal care, represent the socio-economic burden of this disease and constitute more than half of the total indirect costs. Therefore, the obvious gap and hidden social costs of this disease are related to health policymakers, especially when they want to study the impact of this disease on different income classes of families. |
format | Online Article Text |
id | pubmed-8840875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88408752022-03-22 Economic Burden of Epidermolysis Bullosa Disease in Iran Forghani, Siamak Farokh Jahangiri, Reza Ghasemi, Farzaneh Shirani, Reza Bagheri, Hosein Mahmoodi, Razieh Bagheri Faradonbeh, Saeed Med J Islam Repub Iran Original Article Background: Epidermolysis bullosa (EB) is prevalent in Iran and incurs direct and indirect costs on the health care system and the patient. Therefore, this study was conducted to estimate the economic burden of this disease in Iran. Methods: This study includes all patients with EB disease who had been referred to the medical centers of Iran in 2019-2020 for treatment of their disease, especially Hazrat Fatimah Hospital and their medical records are available in Iran EB Patients Association (IEBPA). In estimating the economic burden of diseases and costing studies, we calculated the average direct and indirect costs for a patient and used it to estimate the costs of the patient population. In this study, a prevalence approach was used to calculate the economic burden of this disease. For this purpose, the existing cases of the disease in 2019-2020 were calculated. The data collected from the questionnaires that were completed through interviews with patients as well as the data extracted from the review of their files were entered into Excel software and analyzed. Results: The total direct medical costs of direct non-medical and indirect are equal to 7.319.428.315 & 5.390.440.775 and 45.875.654.514 Rials respectively, and the total economic burden of the disease and the average of each patient is 58.585.514.604 and 155.890.789 respectively. Conclusion: High indirect costs, especially informal care, represent the socio-economic burden of this disease and constitute more than half of the total indirect costs. Therefore, the obvious gap and hidden social costs of this disease are related to health policymakers, especially when they want to study the impact of this disease on different income classes of families. Iran University of Medical Sciences 2021-11-03 /pmc/articles/PMC8840875/ /pubmed/35321378 http://dx.doi.org/10.47176/mjiri.35.146 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Forghani, Siamak Farokh Jahangiri, Reza Ghasemi, Farzaneh Shirani, Reza Bagheri, Hosein Mahmoodi, Razieh Bagheri Faradonbeh, Saeed Economic Burden of Epidermolysis Bullosa Disease in Iran |
title | Economic Burden of Epidermolysis Bullosa Disease in Iran |
title_full | Economic Burden of Epidermolysis Bullosa Disease in Iran |
title_fullStr | Economic Burden of Epidermolysis Bullosa Disease in Iran |
title_full_unstemmed | Economic Burden of Epidermolysis Bullosa Disease in Iran |
title_short | Economic Burden of Epidermolysis Bullosa Disease in Iran |
title_sort | economic burden of epidermolysis bullosa disease in iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840875/ https://www.ncbi.nlm.nih.gov/pubmed/35321378 http://dx.doi.org/10.47176/mjiri.35.146 |
work_keys_str_mv | AT forghanisiamakfarokh economicburdenofepidermolysisbullosadiseaseiniran AT jahangirireza economicburdenofepidermolysisbullosadiseaseiniran AT ghasemifarzaneh economicburdenofepidermolysisbullosadiseaseiniran AT shiranireza economicburdenofepidermolysisbullosadiseaseiniran AT bagherihosein economicburdenofepidermolysisbullosadiseaseiniran AT mahmoodirazieh economicburdenofepidermolysisbullosadiseaseiniran AT bagherifaradonbehsaeed economicburdenofepidermolysisbullosadiseaseiniran |